Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Clinical Pharmacokinetics
|
October 7, 2021
Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling
Jacqueline G Gerhart, Fernando O Carreño, Andrea N Edginton, et al.
Antimicrobial Agents and Chemotherapy
|
March 20, 2013
In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis
Suresh Solapure, Neela Dinesh, Radha Shandil, et al.
Bioanalysis
|
November 8, 2021
REGEN-COV<sup>®</sup> antibody cocktail bioanalytical strategy: comparison of LC-MRM-MS and immunoassay methods for drug quantification
Susan C Irvin, Samit Ganguly, Rachel Weiss, et al.
Frontiers in Immunology
|
March 26, 2026
The role of large immune complexes in anti-drug antibody development: a case study of anti-SARS-CoV-2 antibody therapeutics and co-administered mRNA vaccine
Susan C Irvin, Zhiqiang Wang, Samit Ganguly, et al.
Clinical Pharmacology and Therapeutics
|
December 14, 2023
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development
John D Davis, Marçal Bravo Padros, Daniela J Conrado, et al.
The AAPS Journal
|
October 23, 2025
Association of Immunogenicity and Drug Exposure and the Importance of Target Engagement in ADA Development: A Clinical Case Study of Anti-SARS-CoV-2 Biotherapeutics
Susan C Irvin, Samit Ganguly, Zhiqiang Wang, et al.
Neurobiology of Pain (Cambridge, Mass.)
|
December 15, 2023
Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis pain
Selin Somersan-Karakaya, Kenneth C Turner, Luz Cortes-Burgos, et al.
BMJ Open
|
October 9, 2024
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 study
Thomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Journal of the Pediatric Infectious Diseases Society
|
October 1, 2024
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19
Thomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 5, 2022
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19
Flonza Isa, Eduardo Forleo-Neto, Jonathan Meyer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Clinical Pharmacokinetics
|
October 7, 2021
Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling
Jacqueline G Gerhart, Fernando O Carreño, Andrea N Edginton, et al.
Antimicrobial Agents and Chemotherapy
|
March 20, 2013
In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis
Suresh Solapure, Neela Dinesh, Radha Shandil, et al.
Bioanalysis
|
November 8, 2021
REGEN-COV<sup>®</sup> antibody cocktail bioanalytical strategy: comparison of LC-MRM-MS and immunoassay methods for drug quantification
Susan C Irvin, Samit Ganguly, Rachel Weiss, et al.
Frontiers in Immunology
|
March 26, 2026
The role of large immune complexes in anti-drug antibody development: a case study of anti-SARS-CoV-2 antibody therapeutics and co-administered mRNA vaccine
Susan C Irvin, Zhiqiang Wang, Samit Ganguly, et al.
Clinical Pharmacology and Therapeutics
|
December 14, 2023
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development
John D Davis, Marçal Bravo Padros, Daniela J Conrado, et al.
The AAPS Journal
|
October 23, 2025
Association of Immunogenicity and Drug Exposure and the Importance of Target Engagement in ADA Development: A Clinical Case Study of Anti-SARS-CoV-2 Biotherapeutics
Susan C Irvin, Samit Ganguly, Zhiqiang Wang, et al.
Neurobiology of Pain (Cambridge, Mass.)
|
December 15, 2023
Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis pain
Selin Somersan-Karakaya, Kenneth C Turner, Luz Cortes-Burgos, et al.
BMJ Open
|
October 9, 2024
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 study
Thomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Journal of the Pediatric Infectious Diseases Society
|
October 1, 2024
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19
Thomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 5, 2022
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19
Flonza Isa, Eduardo Forleo-Neto, Jonathan Meyer, et al.
Page
of 3